Location: New York, NY
CIK: 0001826434 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $364M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | LILLY ELI & CO | 105,170 | $34.01M | 9.3% | $278.09 | +10.8% | COM | 532457108 |
| BIIB | BIOGEN INC | 90,551 | $24.18M | 6.6% | $212.38 | 0.0% | COM | 09062X103 |
| ARGX | ARGENX SE | 64,152 | $22.65M | 6.2% | $366.44 | — | SPONSORED ADR | 04016X101 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 196,390 | $20.86M | 5.7% | $101.46 | 0.0% | COM | 64125C109 |
| REGN | REGENERON PHARMACEUTICALS | 30,115 | $20.75M | 5.7% | $625.92 | 0.0% | COM | 75886F107 |
| — | CATALENT INC | 235,320 | $17.03M | 4.7% | $88.43 | — | COM | 148806102 |
| GH | GUARDANT HEALTH INC | 285,948 | $15.39M | 4.2% | $50.13 | +2.4% | COM | 40131M109 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 106,528 | $14.2M | 3.9% | $148.32 | +2.5% | SHS USD | G50871105 |
| EW | EDWARDS LIFESCIENCES CORP | 171,082 | $14.14M | 3.9% | $106.17 | -9.4% | COM | 28176E108 |
| STVN | STEVANATO GROUP S P A | 771,933 | $13.08M | 3.6% | $18.35 | -9.1% | ORD SHS | T9224W109 |
| SAVA | CASSAVA SCIENCES INC | 289,300 | $12.1M | 3.3% | — | — | Call | 14817C107 |
| — | GSK PLC | 409,503 | $12.05M | 3.3% | $29.43 | — | SPONSORED ADR | 37733W105 |
| BLCO | BAUSCH PLUS LOMB CORP | 700,525 | $10.75M | 2.9% | $15.87 | 0.0% | COMMON SHARES | 071705107 |
| — | MIRATI THERAPEUTICS INC | 151,534 | $10.58M | 2.9% | $69.84 | — | COM | 60468T105 |
| SRPT | SAREPTA THERAPEUTICS INC | 95,445 | $10.55M | 2.9% | $100.79 | 0.0% | COM | 803607100 |
| SKIN | THE BEAUTY HEALTH COMPANY | 825,109 | $9.728M | 2.7% | $18.04 | -29.9% | COM CL A | 88331L108 |
| ALLO | ALLOGENE THERAPEUTICS INC | 784,133 | $8.469M | 2.3% | $11.95 | +13.7% | COM | 019770106 |
| — | PROMETHEUS BIOSCIENCES INC | 123,599 | $7.294M | 2.0% | $32.70 | — | COM | 74349U108 |
| MRVI | MARAVAI LIFESCIENCES HLDGS I | 280,811 | $7.169M | 2.0% | $25.09 | 0.0% | COM CL A | 56600D107 |
| — | AKERO THERAPEUTICS INC | 209,248 | $7.125M | 2.0% | $34.05 | — | COM | 00973Y108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 238,569 | $6.706M | 1.8% | $31.38 | -2.3% | COM NEW | 15117B202 |
| CHRS | COHERUS BIOSCIENCES INC | 636,943 | $6.121M | 1.7% | $9.28 | +9.1% | COM | 19249H103 |
| — | KEZAR LIFE SCIENCES INC | 709,733 | $6.111M | 1.7% | $14.37 | — | COM | 49372L100 |
| — | ASTRIA THERAPEUTICS INC | 631,579 | $5.709M | 1.6% | $9.04 | — | COM | 04635X102 |
| NTRA | NATERA INC | 129,955 | $5.695M | 1.6% | $47.60 | 0.0% | COM | 632307104 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 683,613 | $5.517M | 1.5% | $8.07 | — | SPONSORED ADS | 881624209 |
| XENE | XENON PHARMACEUTICALS INC | 134,331 | $4.849M | 1.3% | $30.24 | +18.9% | COM | 98420N105 |
| VTYX | VENTYX BIOSCIENCES INC | 125,000 | $4.364M | 1.2% | $22.14 | 0.0% | COM | 92332V107 |
| — | X4 PHARMACEUTICALS INC | 2,504,006 | $4.282M | 1.2% | $2.07 | — | COM | 98420X103 |
| INSP | INSPIRE MED SYS INC | 23,412 | $4.153M | 1.1% | $199.42 | +0.8% | COM | 457730109 |
| — | IVERIC BIO INC | 190,597 | $3.419M | 0.9% | $17.94 | — | COM | 46583P102 |
| BEAM | BEAM THERAPEUTICS INC | 53,754 | $2.561M | 0.7% | $57.05 | 0.0% | COM | 07373V105 |
| CRSP | CRISPR THERAPEUTICS AG | 36,460 | $2.383M | 0.7% | $72.47 | 0.0% | NAMEN AKT | H17182108 |
| — | BELLUS HEALTH INC NEW | 214,661 | $2.267M | 0.6% | $5.74 | — | COM NEW | 07987C204 |
| ALT | ALTIMMUNE INC | 157,303 | $2.009M | 0.6% | $6.17 | +139.4% | COM NEW | 02155H200 |
| PCVX | VAXCYTE INC | 79,411 | $1.906M | 0.5% | $25.35 | 0.0% | COM | 92243G108 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 199,500 | $1.682M | 0.5% | — | — | Call | 74366E102 |
| — | FIBROGEN INC | 74,348 | $967K | 0.3% | $13.01 | — | COM | 31572Q808 |
| ACLX | ARCELLX INC | 42,826 | $804K | 0.2% | $19.14 | 0.0% | COMMON STOCK | 03940C100 |
| — | LEAP THERAPEUTICS INC | 711,798 | $626K | 0.2% | $0.88 | — | COM | 52187K101 |
| FEMY | FEMASYS INC | 106,606 | $120K | 0.0% | $7.91 | -76.3% | COM | 31447E105 |